SCHEMBL4511424

SCHEMBL4511424

COC(=O)c1ccc(C(C)NC(=O)C(F)(F)F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.51
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
CA12 O43570 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
MAPT P10636 2/20 0.44
MITF O75030 1/20 0.44
TP53 P04637 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21932297 1.00 CNR1 (0.51) CNR1CA1CA2TDP1CA12
SCHEMBL21932490 1.00 CNR1 (0.51) CNR1CA1CA2TDP1CA12
SCHEMBL28413213 0.84 NR1H4 (0.59) CNR1ALDH1A1LMNAKMT2AACACB
SCHEMBL3196971 0.84 NR1H4 (0.59) CNR1ALDH1A1LMNAKMT2AACACB
SCHEMBL28884388 0.83 CNR1 (0.69) CNR1CA1CA2ALDH1A1KMT2A
SCHEMBL20270827 0.80 CNR1 (0.46) CNR1ALDH1A1LMNAMAPTKMT2A
SCHEMBL20270826 0.80 CNR1 (0.46) CNR1ALDH1A1LMNAMAPTKMT2A
SCHEMBL21399858 0.80 CNR1 (0.49) CNR1ALDH1A1CYP2C9HTTKMT2A
SCHEMBL14966445 0.80 ACACB (0.56) CA1CA2TDP1CA12CA7
SCHEMBL19413995 0.80 ACACB (0.56) CA1CA2TDP1CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111132972-B Small molecule modulators of human STING 克拉德夫制药有限公司 2024-07-12 CN disclosed
US-11571423-B2 Small molecule modulators of human sting CURADEV PHARMA LIMITED (GB) 2023-02-07 US disclosed
EP-3642198-B1 SMALL MOLECULE MODULATORS OF HUMAN STING CURADEV PHARMA LTD (GB) 2022-03-16 EP disclosed
EP-3642198-B1 SMALL MOLECULE MODULATORS OF HUMAN STING CURADEV PHARMA LTD (GB) 2022-03-16 EP disclosed
US-20200147083-A1 SMALL MOLECULE MODULATORS OF HUMAN STING CURADEV PHARMA LIMITED (GB) 2020-05-14 US disclosed
CN-111132972-A Small molecule modulators of human STING 克拉德夫制药有限公司 2020-05-08 CN disclosed
US-20090233960-A1 Kinase Inhibitors DEVGEN NV (BE) 2009-09-17 US disclosed
EP-1934181-A2 KINASE INHIBITORS Devgen NV (BE) 2008-06-25 EP disclosed
WO-2007042321-A2 KINASE INHIBITORS DEVGEN N.V. (BE) 2007-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233960-A1 Kinase Inhibitors ROCK1, MAP3K1, MAP3K11 CNR1 2394/4885CA1 1191/4885CA2 513/4885
US-11571423-B2 Small molecule modulators of human sting STING1, IRF3, CGAS CNR1 3529/4885CA1 4880/4885CA2 4260/4885
US-20200147083-A1 SMALL MOLECULE MODULATORS OF HUMAN STING STING1, IRF3, CGAS CNR1 3529/4885CA1 4880/4885CA2 4260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.